People with Parkinson’s and SNCA gene changes
Part of Brain & nervous system clinical trials.
This registry study enrolls people who have Parkinson’s disease and carry certain SNCA gene changes. It aims to better understand how these genetic changes relate to Parkinson’s, which can guide future research and care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with Parkinson’s disease by standard clinical criteria
- You test positive for an SNCA genetic variant (a specific gene change related to Parkinson’s)
- This is a registry, so you’ll likely share health information and possibly genetic or symptom details
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This registry collects information about people with Parkinson’s who have specific changes in the GBA gene. The goal is to better understand how these gene changes affect Parkinson’s and support future research.
This study is a registry that collects information from people with Parkinson’s who have specific LRRK2 gene changes. It helps researchers understand how this genetic form of Parkinson’s behaves over time.
This trial is a research registry that collects health and family information from people with Parkinson’s disease (and sometimes their close relatives). It may help doctors better understand how Parkinson’s runs in families.
This study is a registry that collects information from people with Parkinson’s disease (PD) to better understand the condition, especially in people whose symptoms started by age 50. It may help researchers learn which factors matter most for early-onset PD.
This study is a registry that collects information from people with Parkinson’s disease to better understand the condition. You may help researchers learn about patterns of symptoms and care over time.
This study follows people with Parkinson’s disease, certain Parkinson-like conditions, and some people at higher risk. It helps researchers learn how these illnesses start and progress, which may lead to better earlier detection and care.
Hear when a new Parkinson Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.